Manifestations and outcome of extra-pulmonary tuberculosis: Impact of human immunodeficiency virus co-infection

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 5, 2005, Pages 485-493

  Kwara, Awewura ^a,b   Roahen Harrison, S ^c   Prystowsky, E ^d,e   Kissinger, P ^c   Adams, R ^f   Mathison, J ^f   Hyslop, N E ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Office of Public Health   (United States)

Author keywords

Extra pulmonary tuberculosis; HIV; Manifestations; Outcome

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRAPULMONARY TUBERCULOSIS; FATALITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LABORATORY DIAGNOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPERINFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LOGISTIC MODELS; LOUISIANA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUBERCULOSIS;

EID: 18444413273     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Tuberculosis surveillance reports. Reported tuberculosis in the United States, 2002. Atlanta, GA: CDC, 2002. www.cdc.gov/nchstp/tb/surv/surv2002/default.htm Accessed July 2004.
2. Onorato I M, McCray E and the Field Services Branch. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992; 165: 87-92.
3. Tuberculosis and acquired immunodeficiency syndrome - Florida. MMWR 1986; 35: 587-590.
4. Tuberculosis and acquired immunodeficiency syndrome - New York. MMWR 1987; 36: 785-795.
5. Jones B E, Young S M M, Antoniskis D, et al. Relationship of the manifestation of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292-1297.
6. Barnes P F, Bloch A B, Davidson P T, Snider D E Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
7. Kwara A, Carter E J, Rich J D, Flanigan T P. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients. AIDS Patient Care STDs 2004; 18: 341-347.
8. Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004; 38: 199-205.
9. Ong A, Creasman J, Hopewell P C, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis 2004; 38: 25-31.
10. Shaffer R W, Kim D S, Weiss J P, Quale J M. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70: 384-397.
11. Brainard D, Hyslop N E Jr, Mera R, Churchill J. Long-term outcome of inpatients with tuberculosis assigned to outpatient therapy at a local clinic in New Orleans. J Investig Med 1997; 45: 381-387.
12. Louisiana Office of Public Health. HIV/AIDS update: HIV/ AIDS and tuberculosis. Louisiana Morbidity Report 2000; 11: 5. www.oph.dhh.state.la.us/ stateepidemiologist/infectiousdisease/docs/Lmr/janfeb00.pdf
13. Mehta J B, Dutt A, Harvill L, Mathews K M. Epidemiology of tuberculosis: a comparative analysis with pre-AIDS era. Chest 1991; 99: 1134-1138.
14. Frye M D, Pozsik C J, Sahn S A. Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis. Chest 1997; 112: 393-397.
15. Smith S, Jacobs R F, Wilson C B. Immunobiology of childhood tuberculosis: a window on ontogeny of cellular immunity. J Pediatr 1997; 131: 16-26.
16. Sterling T R, Dorman S E, Chaisson R E, et al. Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis 2001; 33: 976-982.
17. Keane J, Getshon S, Wise R P, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
18. Mohan A K, Coté T R, Block J A, Manadan A M, Siegel J N, Braun M M. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 2004; 39: 295-299.
19. Adjei A, Lartey M. Spectrum of opportunistic infections causing death in patients with AIDS in Ghana: correlation of clinical diagnoses with autopsy results. 11th Conference on Retroviruses and Opportunistic Infections, February 2004, San Francisco, CA. [Abstract #574]. www.retroconference.org/2004/cd/ Absttact/574.htm Accessed 20 July 2004.
20. Pablos-Méndez A, Sterling T R, Frieden T R. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996; 276: 1223-1228.
21. Alpert P L, Munsiff S S, Gourevitch M N, Greenberg B, Klein R S. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997; 24: 661-663.
22. Chow K M, Chow V C, Hung L C, Wong S M, Szeto C C. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascetic fluid samples. Clin Infect Dis 2004; 35: 409-413.
23. Rieder H L, Cauthen G M, Bloch A B, et al. Tuberculosis and acquired immunodeficiency syndrome - Florida. Arch Intern Med 1989; 149: 1268-1273.
24. Huebner R B, Schein M F, Bass J B Jr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
25. Metchock B G, Nolte F S, Wallace R J Jr. Mycobacterium. In: Murray P R, Baron E J, Pfaller M A, Tenofer F C, Yolken R H, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology Press, 1999: 399-437.
26. Piersimoni C, Callegaro A, Scarparo C, et al. Comparative evaluation of the new Gen-Probe Mycobacterium tuberculosis Amplified Direct Test and the semiautomated Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol 1998; 36: 3601-3604.
27. Gamboa F, Fernandez G, Padilla E, et al. Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory sand nonrespiratory specimens. J Clin Microbiol 1998; 36: 684-689.
28. Arend S M, Andersen P, van Metjggaarden K E, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic 6-kDa protein and culture filtrate protein 10. J Infect Dis 2000; 181: 1850-1854.
29. Munk M E, Arend S M, Brock I, Ottenhoff T H, Anderson P. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 2001; 183: 175-176.
30. Bruijnesteijn van Coppenraet E S, Lindeboom J A, Prins J M, Peeters M F, Claas E C J, Kuijper E J. Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol 2004; 42: 2644-2650.
31. Farer L S, Lowell A M, Meador M P. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109: 205-217.
32. García de Olalla P, Martínez-González M A, Caylà J A, et al. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 2002; 6: 1051-1057.
33. Dean G L, Edwards S G, Ives N J, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active anti-retroviral therapy. AIDS 2002; 16: 75-83.
34. Hung C-C, Chen M-Y, Hsiao C-F, Hsieh S-M, Sheng W-H, Chang S-C. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003; 17: 2615-2622.